TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04446468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Psychiatric Hospital Discharge Care
Description: Current VA standard discharge care includes five core elements. First, patients and their outpatient providers are required to be involved in discharge planning. Second, patients should be offered evidence-based treatments to address their mental health symptoms. Third, the inpatient team should work with the patient to complete a safety plan prior to discharge. Fourth, the inpatient team should arrange two follow-up care visits within 30 days of discharge. Fifth, the inpatient team in conjunction with the SPC assess whether patients are appropriate to be placed on the High Risk for Suicide List. Patients who are placed on the High Risk for Suicide List receive enhanced oversight as outlined in VA policy.
Study: NCT01134497

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: The control arm will consist of up to 6 cycles of carboplatin (AUC5 q21d for 6 cycles) iv over 30 minutes on day 1, plus placebo by mouth on days 1-21 of a 21 day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054
Description: The experimental arm will consist of up to 6 cycles of carboplatin (AUC5 q21d for 6 cycles) iv over 30 minutes on day 1, plus ZD4054 (10mg daily) od by mouth on days 1-21 of a 21 day cycle.
Study: NCT04993976

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistant training (Prehabilitation)
Description: Resistance training (10-15 repetitions: major muscle groups of upper and lower limbs \[eg, shoulder overhead press, biceps curl, knee lift, and quadriceps extension in sitting and hamstrings curl exercises\], one to three sets each) for 20-60 minutes five days a week.
Study: NCT05861882

Intervention type: OTHER
Intervention: functional movement screen
Description: FMS consists of seven test component which are used to evaluate various main movement models.Individuals completed one by one deep squat, high stepping, single line lunge, shoulder mobility, straight leg raises, trunk stability push-ups, rotation stability which are component tests. Subcomponent tests assess asymmetry by measuring the individual bilaterally. Each component test was scored on an ordinal scale (0 to 3 points), with a maximum score of 3, based on the quality of the movement. Less than 3 points indicated that the individual performed some form of compensation or was unable to complete the entire movement.While individuals were doing these tests, they were recorded in the video , the final scoring was done by evaluating the images. The scores of the component tests were summed, resulting in a composite score between 0 and 21 points, with a maximum score of 21
Study: NCT04942613

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Qualitative Interview
Description: Qualitative interview to explore patient perspectives of the multicomponent telerehabilitation program (physical therapy, biobehavioral interventions, technology, and social support interventions) and how they contribute to program engagement and participation as well as changes in physical activity.

Intervention type: OTHER
Group type: OTHER
Intervention: Qualitative Interview
Description: Qualitative interview to explore patient perspectives of the multicomponent telerehabilitation program (physical therapy, biobehavioral interventions, technology, and social support interventions) and how they contribute to program engagement and participation as well as changes in physical activity.
Study: NCT04993976

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Control group
Description: Conventional physiotherapy group followed basic pre-operative respiratory physiotherapy including deep breathing exercises, instructions in coughing techniques, mobilization, and active exercises of the upper limbs and thorax. Walk 30 m in the hospital ward.
Study: NCT04491370

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin
Description: All patients will receive a myeloablative conditioning regimens (BEAM or CBV, as selected by the treating physician) followed by autologous stem cell transplant (ASCT). All patients on this study will receive an autologous stem cell transplant (ASCT) on Day 0 followed by supportive care including the drugs sargarmostim and filgrastim until blood counts are stable. If a complete, partial, or stable response is achieved following ASCT, the patient will receive an IV dose of Polatuzumab Vedotin once every 21 days until he/she receives 8 doses.
Study: NCT05214131

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: gogoband
Description: use of biometric alarm to wake patient prior to wetting

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SNEA group
Description: standard bedwetting alarm is used to treat patients, alarm sounds after wetting accident has occurred
Study: NCT05780749

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DDI-IBS-001
Description: The product is a combination of chitin-glucan and other dietary complement components. The dosage of chitin-glucan is 1.5 g/day. The product is a powder for oral administration 1x/day.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: DDDI-IBS-001 placebo
Description: The placebo product has the same composition in excipient, same form and same posology as DDI-IBS-001.
Study: NCT05754268

Intervention type: PROCEDURE
Intervention: Chinese version of the surgical risk assessment system
Description: There is no need to interfere with the patient. Investigators can observe the outcome after using the system for evaluation.
Study: NCT04118491

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: hyperbaric oxygen and sham hyperbaric oxygen
Description: see arm descriptions

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: hyperbaric oxygen and sham hyperbaric oxygen
Description: see arm descriptions
Study: NCT05824624

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ANIMAL-ASSISTED INTERVENTION
Description: It will be ensured that the child is introduced to the goldfish when he is lying in the observation room, that the child will name the fish, and that he will communicate and feed the fish during his stay. Thus, it is aimed to turn the attention of the child to the goldfish while in the emergency room, to distract the child with the fish while all nursing interventions are presented, and to reduce the fear.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Care
Description: Routine nursing care will be provided.
Study: NCT04269993

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis: placebo and medium THC/medium CBD
Description: Vaporized cannabis: placebo and medium THC/medium CBD

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cannabis: placebo and medium THC/medium CBD
Description: Vaporized cannabis: placebo and medium THC/medium CBD
Study: NCT06364462

Intervention type: OTHER
Intervention: lifestyle intervention
Description: Dietary recommendations should consider energy restriction and exclusion of MAFLD-mediating components (processed food, food and beverages high in added fructose). A Mediterranean type diet is advisable. Both aerobic exercise and resistance training effectively reduce liver fat and should be tailored based on patient preferences to ensure long-term adherence.
Study: NCT04985318

Intervention type: DRUG
Intervention: Cablivi®
Description: Intervention with Cablivi® take place outside of the study
Study: NCT05142462

Intervention type: DEVICE
Intervention: Hip arthroplasty
Description: Hip prosthesis surgical implantation
Study: NCT06191757

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: supported with the developmental support program
Description: Babies were developmentally supported with the developmental support program

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: supported with the developmental support program
Description: Babies were developmentally supported with the developmental support program
Study: NCT05548270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DPI-386 Nasal Gel
Description: Subjects will self-administer DPI-386 Nasal Gel or Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will self-administer DPI-386 Nasal Gel or Placebo
Study: NCT05879614

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNZ-2591
Description: NNZ-2591 oral solution (50mg/mL) to be administered twice daily for 13 weeks.
Study: NCT04533672

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI Sequences
Description: New multiparametric MRI techniques
Study: NCT05042882

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition
Description: Enteral nutrition via nasojejunal tube
Study: NCT05297604

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Vascular photobiomodulation (VPBM)
Description: The participants received a 20-minute single session of VPBM. This noninvasive method involves the use of low-power laser coupled to a bracelet designed to transport the light beam transcutaneously over the radial artery. The laser device (DMC Therapy Ec) delivered irradiation with a power of 100 ± 20 mW, wavelength of 660 ± 10 nm (red light) and energy of 120 J applied continuously, with irradiance of 35 W/cm².

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Sham group (simulated vascular photobiomodulation)
Description: Simulated radiation. The participants received a single session.
Study: NCT06217601

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Digital intervention through Tablet
Description: Web-based multi-domain lifestyle training intervention will be conducted to promoted and focus three lifestyles: nutritional advice, exercise and cognitive training; chat communication with research team, and personalized agenda on daily activities and an information library.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital intervention through Tablet
Description: Web-based multi-domain lifestyle training intervention will be conducted to promoted and focus three lifestyles: nutritional advice, exercise and cognitive training; chat communication with research team, and personalized agenda on daily activities and an information library.
Study: NCT06068790

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 28 French sized rigid sheath
Description: The 28Fr is the standard of care sheath size used at this site.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 22 French sized rigid sheath
Description: The 22Fr is the smaller, investigational sheath size to be used in this study.
Study: NCT05227404

Intervention type: DIAGNOSTIC_TEST
Intervention: LumiraDX
Description: Point-of-care test for SARS-CoV-2

Intervention type: DIAGNOSTIC_TEST
Intervention: RightSign
Description: Point-of-care test for SARS-CoV-2

Intervention type: DIAGNOSTIC_TEST
Intervention: Case Control
Description: Genscript assay performed on the plasma sample
Study: NCT05980585

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPM Device
Description: Daily use of the CPM wearable device
Study: NCT06346015

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gamma Entrainment Stimulation
Description: Audio-assisted therapy: receive audio therapy with a specific device for 30 minutes, once in the morning and evening for 3 months.~(Binaural beat treatment group: receive binaural beat treatment with a specific device for 30 minutes, once in the morning and evening, for 3 months.）
Study: NCT05638646

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention group
Description: Practice standard for clinical diagnosis and treatment of chronic obstructive pulmonary disease

Intervention type: OTHER
Group type: OTHER
Intervention: control group
Description: Maintain current treatment
Study: NCT05859295

Intervention type: DEVICE
Group type: OTHER
Intervention: Red Low-Level Light Therapy
Description: Visible red light (633nm) projected onto the face using an light emitting diode (LED) mask
Study: NCT05130203

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MouvMat Exergaming
Description: Sessions engaging with exergaming device.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard Recreational Programming
Description: Conducted by recreational therapists.
Study: NCT05178602

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi Intervention Group
Description: Tai Chi intervention group: routine treatment and tai Chi exercise,5 times a week.
Study: NCT06079021

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CytoSorb
Description: Application of CytoSorb treatment for 72 hours in patients with ACLF
Study: NCT04872660

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gushen Antai Pill
Description: The Gushen Antai Pill (GSATP, Z20030144) is composed of 10 herbs including radix-polygoni multiflori, radix rehmanniae praeparata, cistanche salsa, radix dipsaci, uncaria, semen cuscutae, rhizoma atractylodis macrocephalae, radix scutellariae, radix paeoniae lactiflorae. Its production follows GMP standards and takes the form of water honey pills, each bag of 6g.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo pill
Description: The placebo pill is produced by Beijing boran Pharmaceutical Co., Ltd. It can simulate the appearance, color and smell of GSATP formula, but it has no clinical effect because it has no active ingredients.
Study: NCT05737654

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise with augmented reality glasses
Description: Two days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.
Study: NCT06429722

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NMRA-335140 80 mg
Description: Participants will receive NMRA-335140 at a dose of 80 mg QD, orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered orally
Study: NCT06580002

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riluzole
Description: Given PO

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Given PO
Study: NCT05821166

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: moderate Whole Body Hyperthermia (mWBH)
Description: Patients receiving 3-4 times mWBH
Study: NCT06366191

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prevention algorithm
Description: a health watch adapted to stress and dissociative symptoms

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care for post traumatic stress disorder
Study: NCT05385003

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: anserine
Description: During the study period, subjects are instructed to take one capsule of anserine daily for a total of 3 months. Aside from the prebiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.
Study: NCT04711031

Intervention type: OTHER
Intervention: FLUS
Description: The participating GPs use ultrasonography on a weekly basis and will use the ultrasonography device already available to them; however, the ultrasound machine system and type of transducer will be reported. The GPs will use a 14-zone FLUS scanning protocol that has previously been validated in a general practice setting. Each of the scanning zones on the patient's left side can be denoted from 1L to 7L and from 1R to 7R on the right side. Each scanning zone should be assessed using FLUS. The transducer is placed in the middle of a scanning zone making a cross sectional image of an intercostal space and the underlying pleura blades. The patients will be examined in an upright position. The GPs will be trained in the 14-zone scanning protocol during a FLUS training program prior to recruitment of patients. FLUS pathological findings are predefined, and the variables will be dichotomized into present or not present for each scanning zone.
Study: NCT06582290

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oxford Virtual Autism Assessment Tool (OVAAT)
Description: The OVAAT is an online ASD diagnostic tool that has been designed to identify both the external/observable features of autism but also the internal/experiential features of autism.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oxford Virtual Autism Assessment Tool (OVAAT)
Description: The OVAAT is an online ASD diagnostic tool that has been designed to identify both the external/observable features of autism but also the internal/experiential features of autism.
Study: NCT06583200

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: End Expiratory Occlusion Test
Description: All studied mechanically ventilated patients under post operative sedation. EEO test will be applied to predict probable responder and probable non-responder according to pulse pressure variation in accordance to previous study where the response to volume expansion was defined as an increase in pulse pressure of 5% or more

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: End Expiratory Occlusion Test
Description: All studied mechanically ventilated patients under post operative sedation. EEO test will be applied to predict probable responder and probable non-responder according to pulse pressure variation in accordance to previous study where the response to volume expansion was defined as an increase in pulse pressure of 5% or more

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Passive Leg Raising Test
Description: All studied mechanically ventilated patients under post operative sedation.Passive leg raising test will be applied to predict probable responder and probable non-responder according to the PPV in accordance to previous study where the response to volume expansion was defined as an increase in pulse pressure of at least 10%

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Passive Leg Raising Test
Description: All studied mechanically ventilated patients under post operative sedation.Passive leg raising test will be applied to predict probable responder and probable non-responder according to the PPV in accordance to previous study where the response to volume expansion was defined as an increase in pulse pressure of at least 10%
Study: NCT05609656

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irreversible electroporation
Description: Percutaneous ablation of a metastatic lesion.~Irreversible electroporation is delivered through the NanoKnife system (AngioDynamics, New York, USA). The system is CE approved for medical use.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Description: Just before the reversible electroporation, calcium chloride will be injected into the primary tumor. The electroporation will be delivered as at least four pulses and up to eight pulses. The device is repositioned after each pulse to ensure coverage of the entire surface area of the tumor.~The reversible electroporation regime will be delivered through the endoscopic device EndoVE®, while the ePORE® will be used for pulse generation, both CE approved.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg as an IV infusion every 3 weeks (+/- 3 days) for up to 12 months~Pembrolizumab is an immune checkpoint inhibitor (PD-1-inhibitor).
Study: NCT04916132

Intervention type: PROCEDURE
Intervention: Kidney Biopsy
Description: Harvesting of kidney tissue from people with type 2 diabetes and albuminuria for subsequent analysis
Study: NCT06066242

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Different induction chemotherapy regimens
Description: azacitidine combined with venetoclax or chemotherapy with or without venetoclax

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Different induction chemotherapy regimens
Description: azacitidine combined with venetoclax or chemotherapy with or without venetoclax

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Different induction chemotherapy regimens
Description: azacitidine combined with venetoclax or chemotherapy with or without venetoclax
Study: NCT06498570

Intervention type: DEVICE
Group type: OTHER
Intervention: Intracorneal rings
Description: The (ICRS), intracorneal rings segments implantation surgery
Study: NCT05385003

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sunflower peptide
Description: During the study period, subjects are instructed to take one capsule of Sunflower peptide daily for a total of 3 months. Aside from the prebiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo control
Description: During the study period, subjects are instructed to take one capsule of placebo control daily for a total of 3 months. Aside from the probiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.
Study: NCT04275973

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lower limb prostheses
Description: Standard commercially available prostheses for participants with lower-limb amputation.~Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Study: NCT06581445

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Birdsongs
Description: The participants listened to a clip of birdsongs from laughing thrushes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Birdsongs
Description: The participants listened to a clip of birdsongs from laughing thrushes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: The participants listened to a cheerful Cuckoo Waltz music.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: The participants listened to a cheerful Cuckoo Waltz music.
Study: NCT04275973

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Orthoses for Drop-foot
Description: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.

Intervention type: DEVICE
Group type: OTHER
Intervention: Footwear
Description: Different footwear will be used.
Study: NCT05416879

Intervention type: DEVICE
Intervention: Actigraph GT3X+BT
Description: 7 day monitoring of physical activity, sedentary behaviour and sleep using the Actigraph GT3X+BT
Study: NCT06295523

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Spray
Description: Participants will receive water spraying on their body throughout the climate chamber exposure.